CareDx Drives Personalized Medicine in Transplantation at CEOT
The 2019 theme at CEOT is No Size Fits All: Uncovering the Potential of Personalized Transplantation. AlloSure is prominently featured in the main program. Dr.
“The CEOT program highlights CareDx’s close collaboration with a very large number of the clinical leaders of advances in transplantation. I am glad to see that AlloSure and the clinicians that
Case studies highlighting clinical utility of AlloSure
Tarek Alhamad, M.D., Medical Director of Transplant Nephrology, at Barnes Jewish Medical Center Stanley Jordan, M.D., Director of the Nephrology Division, Ceders Sinai Comprehensive Transplant Center
Panel discussion on AlloSure use in management of lung, heart, and pancreas transplant patients
Kiran Khush, M.D., Associate Professor of Cardiovascular Medicine, Stanford University Medical Center. Mark Nicolls, M.D., Pulmonologist, Stanford University Medical Center Jon A. Kobashigawa, M.D., Director of the Heart Transplant Program of Cedars-Sinai
For more information, please visit: www.CareDx.com.
Forward Looking Statements
This press release includes forward-looking statements, including statements regarding the Company’s partnership with the Cedars-Sinai Comprehensive Transplant Center and Cedars-Sinai’s use of AlloSure in connection with one of its studies. These forward-looking statements are based upon information that is currently available to
Chief Commercial Officer
Integrated Corporate Relations, Inc.
Source: CareDx, Inc.